A Decades-Long Laboratory in Orbit
ROME, July 16 — Since November 2000, the International Space Station has maintained a continuous human presence in low Earth orbit, evolving from an engineering achievement into an enduring platform for scientific research. Among the most consequential lines of investigation aboard the station is the adaptation of medical diagnostics for the microgravity environment — work that will take center stage at the 2026 annual meeting of the Association for Diagnostics & Laboratory Medicine.
There, a dedicated session on space diagnostics will examine how clinical laboratory testing is being redesigned for conditions where gravity no longer governs fluid behavior. The ISS, built through a partnership of five space agencies — NASA, Roscosmos, ESA, JAXA, and the Canadian Space Agency — represents the first major effort to construct, maintain, and crew a space station through international collaboration. Assembly began in 1998, and the station has since grown into a modular complex.
Its significance lies in providing a permanent laboratory for studying the effects of space on the human body and testing technologies essential for future exploration beyond Earth’s orbit. As one of only two operational space stations, it remains a critical testbed for advancing space medicine and engineering.
The record shows that handheld blood analysis on the ISS dates to 2003, when the i-STAT portable analyzer was first deployed aboard the station. That early capability has since been supplemented by more advanced work focused on Lab-on-a-Chip technology — a miniaturized system that integrates multiple laboratory functions onto a single chip. Researchers view this technology as critical for longer-duration missions, where access to ground-based laboratories will be impossible.
What the Twins Study Revealed
Some of the most detailed data on how prolonged spaceflight affects the human body came from the NASA Twins Study, conducted between 2015 and 2016. Astronaut Scott Kelly spent 340 days aboard the ISS while his identical twin, Mark Kelly, remained on Earth.
The study revealed measurable changes in gene expression, telomere length, and immune function. Those findings have directly shaped the design of diagnostic tools for future missions, providing a baseline for understanding the biological shifts that occur during extended stays in microgravity. The Association for Diagnostics & Laboratory Medicine has a history of involvement in space medicine, with its members contributing to the design of diagnostic tools for NASA.
That work has become increasingly urgent as plans for missions beyond low-Earth orbit advance. The upcoming meeting will address specific technical challenges that remain unresolved, offering researchers a venue to present new data on both engineering hurdles and the biological changes observed in astronauts during extended stays on the station.
Engineering Solutions for Microgravity
Fluid handling in microgravity is a persistent problem that affects every aspect of sample preparation and analysis. On Earth, gravity pulls liquids to the bottom of a container, making pipetting and mixing straightforward.
In orbit, surface tension and capillary action dominate, requiring entirely different approaches to ensuring that reagents reach their intended targets and that samples are processed consistently. Researchers have had to develop novel methods for delivering reagents and preparing samples under these conditions. Radiation effects on reagents present another layer of complexity.
The ISS orbits within Earth’s magnetic field, which provides some shielding from cosmic and solar radiation. Even in that protected environment, reagents degrade faster than they would on the ground.
For missions beyond low-Earth orbit, the radiation environment will be far harsher, accelerating the degradation of chemicals and biological materials used in diagnostics. Engineering systems that can withstand that environment while maintaining accuracy and reliability is a core challenge for the field. The 2026 ADLM meeting will serve as a forum where researchers can present new data on these engineering challenges and the biological changes observed in astronauts.
As the ISS continues its role as the primary permanent laboratory for human spaceflight, the diagnostic tools tested there will inform the medical systems for future missions to the Moon, Mars, and beyond. The work being done now, aimed at overcoming the fundamental constraints of microgravity and radiation, is laying the groundwork for a new era of space medicine.
